What is the share price of Novartis India Ltd (NOVARTIND) today?
The share price of NOVARTIND as on 30th June 2025 is ₹1051.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Novartis India Ltd (NOVARTIND) share?
The past returns of Novartis India Ltd (NOVARTIND) share are- Past 1 week: -0.70%
- Past 1 month: -6.12%
- Past 3 months: 33.99%
- Past 6 months: 10.26%
- Past 1 year: -4.71%
- Past 3 years: 71.72%
- Past 5 years: 54.99%
What are the peers or stocks similar to Novartis India Ltd (NOVARTIND)?
The peers or stocks similar to Novartis India Ltd (NOVARTIND) include:What is the dividend yield % of Novartis India Ltd (NOVARTIND) share?
The current dividend yield of Novartis India Ltd (NOVARTIND) is 2.38.What is the market cap of Novartis India Ltd (NOVARTIND) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novartis India Ltd (NOVARTIND) is ₹2597.22 Cr as of 30th June 2025.What is the 52 week high and low of Novartis India Ltd (NOVARTIND) share?
The 52-week high of Novartis India Ltd (NOVARTIND) is ₹1248 and the 52-week low is ₹744.95.What is the PE and PB ratio of Novartis India Ltd (NOVARTIND) stock?
The P/E (price-to-earnings) ratio of Novartis India Ltd (NOVARTIND) is 25.74. The P/B (price-to-book) ratio is 3.49.Which sector does Novartis India Ltd (NOVARTIND) belong to?
Novartis India Ltd (NOVARTIND) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Novartis India Ltd (NOVARTIND) shares?
You can directly buy Novartis India Ltd (NOVARTIND) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Novartis India Ltd
NOVARTIND Share Price
1,051.904.89% (+49.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NOVARTIND Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NOVARTIND Performance & Key Metrics
NOVARTIND Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.74 | 3.49 | 2.38% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.56 | 6.60 | 0.83% |
NOVARTIND Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NOVARTIND Company Profile
Novartis India Limited manufactures drugs, medicines and allied products. The Company is engaged in the wholesale of pharmaceuticals and medical goods.
SUNPHARMA
PE Ratio
36.79
36.79
1Y Return
10.24%
10.24%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.07
23.07
1Y Return
1.81%
1.81%
Buy Reco %
74.19
74.19
TORNTPHARM
PE Ratio
60.36
60.36
1Y Return
22.54%
22.54%
Buy Reco %
75.00
75.00
DRREDDY
PE Ratio
18.88
18.88
1Y Return
0.99%
0.99%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
22.01
22.01
1Y Return
7.25%
7.25%
Buy Reco %
46.43
46.43
NOVARTIND Forecast
NOVARTIND Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NOVARTIND
NOVARTIND
Income
Balance Sheet
Cash Flow
Annual Normal View
NOVARTIND Income Statement
NOVARTIND Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 727.22 | 735.72 | 568.94 | 568.83 | 486.82 | 519.85 | 471.63 | 428.52 | 398.23 | 398.24 | ||||||||||
Raw Materials | 321.33 | 214.55 | 202.60 | 180.49 | 135.88 | 187.26 | 199.34 | 189.98 | 264.85 | 264.85 | ||||||||||
| Power & Fuel Cost | 1.77 | 2.56 | 1.79 | 1.27 | 0.53 | 0.53 | 0.35 | 0.18 | ||||||||||||
| Employee Cost | 139.30 | 144.53 | 117.11 | 113.87 | 108.51 | 101.89 | 35.64 | 22.96 | ||||||||||||
| Selling & Administrative Expenses | 126.89 | 122.50 | 107.03 | 174.87 | 128.11 | 144.40 | 82.78 | 65.55 | ||||||||||||
| Operating & Other expenses | 41.89 | 86.00 | 49.87 | 50.16 | 53.91 | 75.11 | 30.33 | 22.91 | ||||||||||||
EBITDA | 96.04 | 165.58 | 90.54 | 48.17 | 59.88 | 10.66 | 123.19 | 126.94 | 133.38 | 133.39 | ||||||||||
| Depreciation/Amortization | 3.59 | 2.53 | 3.18 | 13.14 | 12.16 | 9.65 | 6.06 | 2.61 | 2.19 | 2.20 | ||||||||||
| PBIT | 92.45 | 163.05 | 87.36 | 35.03 | 47.72 | 1.01 | 117.13 | 124.33 | 131.19 | 131.19 | ||||||||||
| Interest & Other Items | 0.72 | 5.53 | 1.59 | 6.39 | 7.68 | 4.83 | 1.75 | 1.49 | 0.77 | 0.77 | ||||||||||
| PBT | 91.73 | 157.52 | 85.77 | 28.64 | 40.04 | -3.82 | 115.38 | 122.84 | 130.42 | 130.42 | ||||||||||
| Taxes & Other Items | 34.51 | 79.16 | 34.00 | 18.56 | 19.14 | -0.10 | 12.02 | 37.65 | 29.52 | 29.52 | ||||||||||
| Net Income | 57.22 | 78.36 | 51.77 | 10.08 | 20.90 | -3.72 | 103.36 | 85.19 | 100.90 | 100.90 | ||||||||||
| EPS | 19.04 | 29.66 | 20.97 | 4.08 | 8.46 | -1.51 | 41.86 | 34.50 | 40.87 | 40.87 | ||||||||||
| DPS | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 47.50 | 25.00 | 25.00 | 25.00 | ||||||||||
| Payout ratio | 0.53 | 0.34 | 0.48 | 2.45 | 1.18 | — | 1.13 | 0.72 | 0.61 | 0.61 |
NOVARTIND Company Updates
NOVARTIND Stock Peers
NOVARTIND Past Performance & Peer Comparison
NOVARTIND Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Novartis India Ltd | 25.74 | 3.49 | 2.38% |
| Sun Pharmaceutical Industries Ltd | 36.79 | 5.99 | 0.95% |
| Cipla Ltd | 23.07 | 3.89 | 1.06% |
| Torrent Pharmaceuticals Ltd | 60.36 | 16.82 | 0.94% |
NOVARTIND Stock Price Comparison
Compare NOVARTIND with any stock or ETFCompare NOVARTIND with any stock or ETF
NOVARTIND
NOVARTIND Holdings
NOVARTIND Shareholdings
NOVARTIND Promoter Holdings Trend
NOVARTIND Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NOVARTIND Institutional Holdings Trend
NOVARTIND Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NOVARTIND Shareholding Pattern
NOVARTIND Shareholding Pattern
NOVARTIND Shareholding History
NOVARTIND Shareholding History
Mutual Funds
Mutual Funds Invested in NOVARTIND
Mutual Funds Invested in NOVARTIND
No mutual funds holding trends are available
Top 1 Mutual Funds holding Novartis India Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.05% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 94/109 (-4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing NOVARTIND stock
smallcases containing NOVARTIND stock
Looks like this stock is not in any smallcase yet.
NOVARTIND Events
NOVARTIND Events
NOVARTIND Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NOVARTIND has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.49%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹24.93 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NOVARTIND Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NOVARTIND has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.49%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹24.93 every year
NOVARTIND Upcoming Dividends
NOVARTIND Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 23, 2025
Final
Final | Div/Share: ₹25.00
Dividend/Share
₹25.00
Ex DateEx Date
Jul 23, 2025
NOVARTIND Past Dividends
NOVARTIND Past Dividends
Cash Dividend
Ex DateEx DateJul 23, 2024
Final
Final | Div/Share: ₹25.00
Dividend/Share
₹25.00
Ex DateEx Date
Jul 23, 2024
Cash Dividend
Ex DateEx DateJul 20, 2023
Final
Final | Div/Share: ₹10.00
Dividend/Share
₹10.00
Ex DateEx Date
Jul 20, 2023
Cash Dividend
Ex DateEx DateJul 20, 2023
Special
Special | Div/Share: ₹37.50
Dividend/Share
₹37.50
Ex DateEx Date
Jul 20, 2023
Cash Dividend
Ex DateEx DateJul 20, 2022
Final
Final | Div/Share: ₹10.00
Dividend/Share
₹10.00
Ex DateEx Date
Jul 20, 2022
Cash Dividend
Ex DateEx DateAug 17, 2021
Final
Final | Div/Share: ₹10.00
Dividend/Share
₹10.00
Ex DateEx Date
Aug 17, 2021
NOVARTIND Stock News & Opinions
NOVARTIND Stock News & Opinions
Articles & Videos
Corporate
Board of Novartis India recommends final dividend
Novartis India announced that the Board of Directors of the Company at its meeting held on 9 May 2025, inter alia, have recommended the final dividend of Rs 25 per equity Share (i.e. 500%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Novartis India schedules AGM
Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be held on 31 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024. For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales83.8881.17 3 356.27335.07 6 OPM %28.5113.81 -25.6619.48 - PBDT34.4221.47 60 132.61125.45 6 PBT33.8921.33 59 130.42122.84 6 NP29.3014.68 100 100.9085.19 18 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Novartis India to announce Quarterly Result
Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Novartis India standalone net profit declines 4.22% in the December 2024 quarter
Net profit of Novartis India declined 4.22% to Rs 25.45 crore in the quarter ended December 2024 as against Rs 26.57 crore during the previous quarter ended December 2023. Sales rose 10.01% to Rs 93.00 crore in the quarter ended December 2024 as against Rs 84.54 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.0084.54 10 OPM %27.5123.39 - PBDT35.8241.57 -14 PBT35.2941.31 -15 NP25.4526.57 -4 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Novartis India to hold board meeting
Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Novartis India standalone net profit declines 13.81% in the September 2024 quarter
Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 as against Rs 23.68 crore during the previous quarter ended September 2023. Sales rose 10.60% to Rs 87.11 crore in the quarter ended September 2024 as against Rs 78.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales87.1178.76 11 OPM %20.6321.47 - PBDT28.1533.08 -15 PBT27.5632.43 -15 NP20.4123.68 -14 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Novartis India schedules board meeting
Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
💎जैन सा'ब के GEMS... | Novartis India: Sandeep Jain’s Investment Secrets and Future Predictions!
10 months agoZee Business
Novartis India standalone net profit rises 27.05% in the June 2024 quarter
11 months agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of -6.88%, vs industry avg of 10.2%
Over the last 5 years, market share decreased from 0.23% to 0.1%
Over the last 5 years, net income has grown at a yearly rate of 58.52%, vs industry avg of 20.11%